October Deal Frenzy: Biotech Giants Strike Billion-Dollar Partnerships and Pave New R&D Paths 12 months ago ByJohnIn BreakthroughsDealsPartnershipsPharma Industry UpdatesTop Stories
KSQ Therapeutics Receives FDA Clearance to Advance CRISPR-Edited Cell Therapy for Advanced Solid Tumors 12 months ago ByJohnIn Biopharma HighlightsBreakthroughsClinical TrialsFDA ApprovalsTop Stories
FDA Advisory Panel Recommends Sarepta’s Gene Therapy for Duchenne Muscular Dystrophy 12 months ago ByJohnIn Biopharma HighlightsFDA ApprovalsResearch UpdatesTop Stories
US Biotech Faces VC Slowdown, but Startups Adapt with New Strategies 12 months ago ByJohnIn Biopharma HighlightsFunding RoundsTop StoriesVenture Capital
Vertex and CRISPR Therapeutics Secure First-Ever FDA Approval for CRISPR-Based Therapy in Sickle Cell Disease 12 months ago ByJohnIn Biopharma HighlightsFDA ApprovalsResearch UpdatesTop Stories
Griffith University Launches $14M Clinical Trial for Spinal Cord Injury Using Nasal Cell Transplants 1 year ago ByJohnIn Clinical Trials
Replicor Secures $180M Series C to Expand RNA Amplification Platform Beyond Hepatitis B 1 year ago ByJohnIn Pharma Industry UpdatesTop StoriesVenture Capital
FDA Grants RMAT Designation to ExoGene’s Exosome-Based Gene Therapy for ALS 1 year ago ByJohnIn FDA ApprovalsInvestmentsPharma Industry Updates
mRNA-4157/V940 Shows Durable Response in Melanoma: Moderna and Merck’s Cancer Vaccine Hits Key Milestone 1 year ago ByJohnIn Clinical TrialsPharma Industry Updates
